[TimAlerts] RGLS nhod

[TimAlerts] RGLS Foresite Capital reports 5.26% passive stake in Regulus

[TimAlerts] RGLS Regulus Therapeutics Given “Buy” Rating at Wedbush. Low on 1 yr. chart

[TimChallenge] Both $BEAT and RGLS closed nicely. Should be strong for the opening on Monday.

[TimChallenge] RGLS risk $7.98. Upside target $9ish

[TimChallenge] Bot RGLS at $8.10 short term b/o above $8

[TimAlerts] RGLS big negative spikes suddently

[TimAlerts] RGLS recovering after taking a hit. still down 8.27%. Not sure if it'll keep recovering, but may be worth a look

[TimAlerts] RGLS nhod Lots of volume

[TimAlerts] RGLS nhod